Multi-drug resistant gram-negative bacteria (MDR-GNB) present a significant threat to successful antimicrobial chemotherapy. Among MDR-GNB, Acinetobacter baumannii that are resistant to cephalosporins, carbapenems, and quinolones are becoming a global problem. Our analysis of MDR A. baumannii isolates recovered from military medical facilities treating civilian and military personnel injured in Iraq/Kuwait (Operation Iraqi Freedom) and Afghanistan (Operation Enduring Freedom) showed that the Acinetobacter derived cephalosporinase (ADC), OXA-23 and OXA-58 like carbapenemases are the major reasons for ceftazidime and imipenem resistance. We learned that: 1) ADC is a unique cephalosporinase among the class C enzymes; 2) efflux pumps contribute significantly to quinolone resistance; and 3) the regulation of the AdeABC efflux pump is central to the expression of the MDR phenotype in A. baumannii. The pressing challenge is to understand the genetic and amino acid sequence requirements for beta-lactam resistance, kinetic properties and atomic structures of the ADC and OXA carbapenemases, and the contribution of the efflux pump in MDR A. baumannii.
The aims of this proposal are: 1) to determine the atomic structure of the ADC-7 beta-lactamase and to test novel boronic acid and sulfone transition state inhibitors in order to reveal important structure activity relationships that will guide new inhibitor design; 2) to explore the amino acid requirements for imipenem hydrolysis by OXA carbapenemases and to determine the structure of OXA-23; 3) to elucidate the role of quorum sensing and biofilm formation in MDR A. baumannii; and 4) to determine the genetic variability of the regulatory region (adeR-adeS) of the efflux pump (AdeABC) of MDR isolates by DNA sequencing. We will correlate our sequence analysis of adeR-adeS with a rapid automated PCR based electrospray ionization mass spectrometry method linked with base composition analysis that can detect mutations. Accomplishing these goals will achieve an unprecedented understanding of the protein and substrate interactions and genetic properties responsible for the MDR phenotype. This work will also serve as a paradigm for the rapid diagnosis and prediction of novel MDR phenotypes in A. baumannii, form a basis for the evaluation of novel beta-lactams, and show how enzyme drug targets influence substrate affinity and catalysis. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI072219-02
Application #
7470683
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Korpela, Jukka K
Project Start
2007-08-01
Project End
2012-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
2
Fiscal Year
2008
Total Cost
$367,115
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Stewart, Alesha C; Bethel, Christopher R; VanPelt, Jamie et al. (2017) Clinical Variants of New Delhi Metallo-?-Lactamase Are Evolving To Overcome Zinc Scarcity. ACS Infect Dis 3:927-940
Wilson, Brigid M; El Chakhtoura, Nadim G; Patel, Sachin et al. (2017) Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015. Emerg Infect Dis 23:878-880
Papp-Wallace, Krisztina M; Becka, Scott A; Zeiser, Elise T et al. (2017) Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. ACS Infect Dis 3:502-511
Thom, Kerri A; Rock, Clare; Jackson, Sarah S et al. (2017) Factors Leading to Transmission Risk of Acinetobacter baumannii. Crit Care Med 45:e633-e639
Evans, Scott R; Hujer, Andrea M; Jiang, Hongyu et al. (2017) Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III. J Clin Microbiol 55:134-144
Barnes, Melissa D; Winkler, Marisa L; Taracila, Magdalena A et al. (2017) Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from ?-Lactamase Protein Engineering. MBio 8:
Viau, Roberto A; Kiedrowski, Lee M; Kreiswirth, Barry N et al. (2017) A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST. Pathog Immun 2:23-33
Ruggiero, Melina; Papp-Wallace, Krisztina M; Taracila, Magdalena A et al. (2017) Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam Inactivation of PER-2 ?-Lactamase. Antimicrob Agents Chemother 61:
Marshall, Steven; Hujer, Andrea M; Rojas, Laura J et al. (2017) Can Ceftazidime-Avibactam and Aztreonam Overcome ?-Lactam Resistance Conferred by Metallo-?-Lactamases in Enterobacteriaceae? Antimicrob Agents Chemother 61:
Rojas, Laura J; Hujer, Andrea M; Rudin, Susan D et al. (2017) NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas. Antimicrob Agents Chemother 61:

Showing the most recent 10 out of 156 publications